Page last updated: 2024-08-26

mci 9038 and Shock, Septic

mci 9038 has been researched along with Shock, Septic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beyer, J; Halbritter, K; Schellong, S; Weise, M	1
Fries, D	2
Bécanne, X; De Mesmay, M; Flaujac, C; Gauzit, R; Godier, A; Horellou, MH; Parisot, M; Samama, CM	1
Bellmann, R; Dunzendorfer, S; Joannidis, M; Pechlaner, C; Schusterschitz, N; Stein, M	1

Reviews

2 review(s) available for mci 9038 and Shock, Septic

Article	Year
[Anticoagulation in critically ill patient]. Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:19-20 Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis	2009
Thrombosis prophylaxis in critically ill patients. Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:3-4 Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis	2011

Article

Year

[Anticoagulation in critically ill patient].

Wiener medizinische Wochenschrift (1946), 2009, Volume: 159, Issue:19-20

Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis

2009

Thrombosis prophylaxis in critically ill patients.

Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:3-4

Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis

2011

Other Studies

3 other study(ies) available for mci 9038 and Shock, Septic

Article	Year
Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shock. Thrombosis research, 2009, Volume: 124, Issue:3 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Blood Coagulation; Female; Humans; Pipecolic Acids; Shock, Septic; Sulfonamides; Thrombosis	2009
Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report. Thrombosis research, 2010, Volume: 126, Issue:2 Topics: Acute Kidney Injury; Adult; Anticoagulants; Arginine; Heparin; Humans; Male; Obesity, Morbid; Pipecolic Acids; Renal Replacement Therapy; Respiratory Distress Syndrome; Shock, Septic; Sulfonamides; Thrombocytopenia	2010
Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock. Intensive care medicine, 2008, Volume: 34, Issue:7 Topics: Anticoagulants; Arginine; Fatal Outcome; Female; Hemofiltration; Heparin; Humans; Middle Aged; Multiple Organ Failure; Pipecolic Acids; Shock, Septic; Sulfonamides; Thrombocytopenia	2008